Literature DB >> 19467234

Molecular and mass spectral identification of the broadly conserved decapod crustacean neuropeptide pQIRYHQCYFNPISCF: the first PISCF-allatostatin (Manduca sexta- or C-type allatostatin) from a non-insect.

Elizabeth A Stemmler1, Emily A Bruns, Christopher R Cashman, Patsy S Dickinson, Andrew E Christie.   

Abstract

The PISCF-allatostatins (Manduca sexta- or C-type allatostatins) are a family of pentadecapeptides characterized by a pyroglutamine blocked N-terminus, an unamidated-PISCF C-terminus, and a disulfide bridge between two internal Cys residues. Several isoforms of PISCF-AST are known, all from holometabolous insects. Using a combination of transcriptomics and mass spectrometry, we have identified the first PISCF-type peptides from a non-insect species. In silico analysis of crustacean ESTs identified several Litopenaeus vannamei (infraorder Penaeidea) transcripts encoding putative PISCF-AST precursors. Translation of these ESTs, with subsequent prediction of their putative post-translational processing, revealed the existence of as many as three PISCF-type peptides, including pQIRYHQCYFNPISCF (disulfide bridging between Cys(7) and Cys(14)). Although none of the predicted isoforms was detected by mass spectrometry in L. vannamei, MALDI-FTMS mass profiling identified an m/z signal corresponding to pQIRYHQCYFNPISCF (disulfide bridge present) in neural tissue from 28 other decapods, which included members of six infraorders (Stenopodidea, Astacidea, Thalassinidea, Achelata, Anomura and Brachyura). Further characterization of the peptide using SORI-CID and chemical derivatization/enzymatic digestion supported the theorized structure. In both the crab Cancer borealis and the lobster Homarus americanus, MALDI-based tissue surveys suggest that pQIRYHQCYFNPISCF is broadly distributed in the nervous system; it was also detected in the posterior midgut caecum. Collectively, our data show that members of the PISCF-AST family are not restricted to the holometabolous insects, but instead may be broadly conserved within the Pancrustacea. Moreover, our data suggest that one highly conserved PISCF-type peptide, pQIRYHQCYFN-PISCF, is present in decapod crustaceans, functioning as a brain-gut paracrine/hormone.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19467234      PMCID: PMC3538855          DOI: 10.1016/j.ygcen.2009.05.010

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  41 in total

1.  Allatostatin modulates skeletal muscle performance in crustaceans through pre- and postsynaptic effects.

Authors:  S Kreissl; T Weiss; S Djokaj; O Balezina; W Rathmayer
Journal:  Eur J Neurosci       Date:  1999-07       Impact factor: 3.386

2.  Internal calibration on adjacent samples (InCAS) with Fourier transform mass spectrometry.

Authors:  P B O'Connor; C E Costello
Journal:  Anal Chem       Date:  2000-12-15       Impact factor: 6.986

3.  Molecular cloning and characterization of FGLamide allatostatin gene from the prawn, Macrobrachium rosenbergii.

Authors:  Guo-Li Yin; Jin-Shu Yang; Jun-Xia Cao; Wei-Jun Yang
Journal:  Peptides       Date:  2006-01-10       Impact factor: 3.750

4.  Mass spectrometric characterization and physiological actions of VPNDWAHFRGSWamide, a novel B type allatostatin in the crab, Cancer borealis.

Authors:  Qiang Fu; Lamont S Tang; Eve Marder; Lingjun Li
Journal:  J Neurochem       Date:  2007-03-29       Impact factor: 5.372

5.  Biochemical and molecular characterization of allatotropin and allatostatin from the Eri silkworm, Samia cynthia ricini.

Authors:  Zhentao Sheng; Li Ma; Mei-Xun Cao; Sheng Li; Rong-Jing Jiang
Journal:  Insect Biochem Mol Biol       Date:  2006-10-04       Impact factor: 4.714

6.  Gene discovery in Carcinus maenas and Homarus americanus via expressed sequence tags.

Authors:  David W Towle; Christine M Smith
Journal:  Integr Comp Biol       Date:  2006-05-17       Impact factor: 3.326

7.  High-mass-resolution direct-tissue MALDI-FTMS reveals broad conservation of three neuropeptides (APSGFLGMRamide, GYRKPPFNGSIFamide and pQDLDHVFLRFamide) across members of seven decapod crustaean infraorders.

Authors:  Elizabeth A Stemmler; Christopher R Cashman; Daniel I Messinger; Noah P Gardner; Patsy S Dickinson; Andrew E Christie
Journal:  Peptides       Date:  2007-08-25       Impact factor: 3.750

8.  Identification of SYWKQCAFNAVSCFamide: a broadly conserved crustacean C-type allatostatin-like peptide with both neuromodulatory and cardioactive properties.

Authors:  Patsy S Dickinson; Teerawat Wiwatpanit; Emily R Gabranski; Rachel J Ackerman; Jake S Stevens; Christopher R Cashman; Elizabeth A Stemmler; Andrew E Christie
Journal:  J Exp Biol       Date:  2009-04       Impact factor: 3.312

9.  Molecular cloning of four cDNAs encoding prepro-crustacean hyperglycemic hormone (CHH) from the eyestalk of the red rock crab Cancer productus: identification of two genetically encoded CHH isoforms and two putative post-translationally derived CHH variants.

Authors:  Yun-Wei A Hsu; John R Weller; Andrew E Christie; Horacio O de la Iglesia
Journal:  Gen Comp Endocrinol       Date:  2007-09-19       Impact factor: 2.822

10.  Allatostatin decreases stomatogastric neuromuscular transmission in the crab Cancer borealis.

Authors:  J Jorge-Rivera; E MarderY
Journal:  J Exp Biol       Date:  1997-12       Impact factor: 3.312

View more
  20 in total

Review 1.  Crustacean neuropeptides.

Authors:  Andrew E Christie; Elizabeth A Stemmler; Patsy S Dickinson
Journal:  Cell Mol Life Sci       Date:  2010-08-21       Impact factor: 9.261

2.  Distribution of C-type allatostatin (C-AST)-like immunoreactivity in the central nervous system of the copepod Calanus finmarchicus.

Authors:  Caroline H Wilson; Andrew E Christie
Journal:  Gen Comp Endocrinol       Date:  2010-03-23       Impact factor: 2.822

3.  Distribution and physiological effects of B-type allatostatins (myoinhibitory peptides, MIPs) in the stomatogastric nervous system of the crab Cancer borealis.

Authors:  Theresa M Szabo; Ruibing Chen; Marie L Goeritz; Ryan T Maloney; Lamont S Tang; Lingjun Li; Eve Marder
Journal:  J Comp Neurol       Date:  2011-09-01       Impact factor: 3.215

4.  A review of FMRFamide- and RFamide-like peptides in metazoa.

Authors:  Robert J Walker; Sylvana Papaioannou; Lindy Holden-Dye
Journal:  Invert Neurosci       Date:  2010-02-26

5.  Prediction of a neuropeptidome for the eyestalk ganglia of the lobster Homarus americanus using a tissue-specific de novo assembled transcriptome.

Authors:  Andrew E Christie; Vittoria Roncalli; Matthew C Cieslak; Micah G Pascual; Andy Yu; Tess J Lameyer; Meredith E Stanhope; Patsy S Dickinson
Journal:  Gen Comp Endocrinol       Date:  2016-11-05       Impact factor: 2.822

6.  Mass spectrometric characterization of the neuropeptidome of the ghost crab Ocypode ceratophthalma (Brachyura, Ocypodidae).

Authors:  Limei Hui; Brandon T D'Andrea; Chenxi Jia; Zhidan Liang; Andrew E Christie; Lingjun Li
Journal:  Gen Comp Endocrinol       Date:  2013-01-05       Impact factor: 2.822

Review 7.  Function-driven discovery of neuropeptides with mass spectrometry-based tools.

Authors:  Claire M Schmerberg; Lingjun Li
Journal:  Protein Pept Lett       Date:  2013-06       Impact factor: 1.890

8.  Identification of a calcitonin-like diuretic hormone that functions as an intrinsic modulator of the American lobster, Homarus americanus, cardiac neuromuscular system.

Authors:  A E Christie; J S Stevens; M R Bowers; M C Chapline; D A Jensen; K M Schegg; J Goldwaser; M A Kwiatkowski; T K Pleasant; L Shoenfeld; L K Tempest; C R Williams; T Wiwatpanit; C M Smith; K M Beale; D W Towle; D A Schooley; P S Dickinson
Journal:  J Exp Biol       Date:  2010-01-01       Impact factor: 3.312

Review 9.  Neuromodulation of neuronal circuits: back to the future.

Authors:  Eve Marder
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

10.  Combining in silico transcriptome mining and biological mass spectrometry for neuropeptide discovery in the Pacific white shrimp Litopenaeus vannamei.

Authors:  Mingming Ma; Ashley L Gard; Feng Xiang; Junhua Wang; Naveed Davoodian; Petra H Lenz; Spencer R Malecha; Andrew E Christie; Lingjun Li
Journal:  Peptides       Date:  2009-10-21       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.